This startup utilizes smartphone-based eye-tracking technology to generate digital biomarkers for cognitive health monitoring, enabling continuous and objective assessment of visual behavior. By detecting subtle changes in eye movements, the platform facilitates early identification of neurodegenerative diseases, such as Alzheimer's and Parkinson's, before significant symptoms arise.
Funding
Funding not disclosed
Founders
Product
Problem
Early detection of neurodegenerative diseases like Alzheimer's and Parkinson's is challenging due to subtle cognitive changes that occur years before diagnosis. Traditional methods lack continuous, objective monitoring capabilities to identify these early indicators effectively. Current tools also struggle to provide objective measurements of impairments due to concussion.
Solution
mye health offers a smartphone-based eye-tracking platform that uses a "Blue Dot" game to generate digital biomarkers for brain health monitoring. By analyzing eye movements during gameplay, the platform objectively measures cognitive function and detects subtle impairments related to neurodegenerative diseases and concussions. The platform facilitates continuous assessment of visual behavior, enabling early identification of cognitive decline and tracking the progression and treatment efficacy of mild traumatic brain injury (mTBI).
Target Audience
The primary target audience includes individuals at risk of neurodegenerative diseases, patients recovering from concussions, and healthcare providers seeking objective tools for cognitive assessment.
Features
- Smartphone-based eye-tracking technology for convenient and accessible brain health monitoring.
- "Blue Dot" game interface, based on the WebGrid game from Neuralink, for engaging and continuous eye movement analysis.
- Gaze point metrics to measure and quantify brain health indicators.
- Objective measurement of impairments due to concussion.
- Continuous monitoring of eye movement impairments for tracking mTBI progression and treatment efficacy.
- Support for Samsung Galaxy S5 (or newer), Samsung Galaxy Note20, Tab4, Tab S2, Tab A7 (or newer), iPhone 8 (or newer), and iPad Pro, Air, and Mini devices.
- Brief Fatigue Inventory (BFI) to assess the severity and impact of fatigue.